Leerink Partners analyst Richard Newitter maintained a Buy rating on Align Tech (NASDAQ:ALGN) on Tuesday, setting a price target of $310, which is approximately 13.43% above the present share price of $273.29.
Newitter expects Align Tech to post earnings per share (EPS) of $19.32 for the third quarter of 2020.
The current consensus among 6 TipRanks analysts is for a Moderate Buy rating of shares in Align Tech, with an average price target of $280.6.
The analysts price targets range from a high of $325 to a low of $245.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $550.96 million and a net profit of $69.92 million. The company's market cap is $21.28 billion.
According to TipRanks.com, Leerink Partners analyst Richard Newitter is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 22.5% and a 66.12% success rate.
Align Technology , Inc. engages in the manufacture, design, and marketing of global medical devices. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of invisalign full, teen and assist products, and vivera retainers along with training and ancillary products for treating malocclusion. The Scanner and Services segment comprises of intraoral scanning systems and additional services available with the intraoral scanners that provide digital alternatives to the traditional cast models. The company was founded by Zia Chishti, Brian Freyburger and Kelsey Wirth in March 1997 and is headquartered in San Jose, CA.